Single dose application of cetrorelix in combination with clomiphene for friendly IVF: Results of a feasibility study

Reproductive BioMedicine Online

Volumn 6, Issue 4, 2003, Pages 444-447

  Engel, Jôrg Bernhard ^a   Olivennes, F ^a   Fanchin, R ^a   Frydman, N ^a   Le Du A ^a   Blanchet, V ^a   Frydman, R ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Clomiphene; COS; Friendly IVF; LHRH antagonist

Indexed keywords

CETRORELIX; CLOMIFENE; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; FEASIBILITY STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LUTEINIZING HORMONE RELEASE; OVARY DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

EID: 0038236540     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)62165-7     Document Type: Article

References (20)

1. Adashi EY 1984 Clomiphene citrate: mechanism(s) and site(s) of action - hypothesis revisited. Fertility and Sterility 42, 331-344.
2. Albano C, Smitz J, Camus M et al. 1997 Comparison of different doses of gonadotrophin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation. Fertility and Sterility 67, 917-922.
3. Albano C, Felberbaum RE, Smitz J et al. 2000 Ovarian stimulation with HMG: results of a prospective randomised phase III European study comparing the luteinizing-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist Buserelin. Human Reproduction 15, 526-531.
4. Diedrich K, Diedrich C, Santos E et al. 1994 Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation. Human Reproduction 9, 788-791.
5. Edwards R, Lobo R, Bouchard P 1996 Time to revolutionize ovarian stimulation. Human Reproduction 11, 917-919.
6. Emons G, Ortmann O, Thiessen S, Knuppen R 1986 Effects of estradiol and some antiestrogens (clomiphene, tamoxifen and hydrotamoxifen) on luteinizing hormone secretion by rat pituitary cells in culture. Archives of Gynecology 237, 199-211.
7. Engel JB, Albano C, Felberbaum R et al. 2001 Attempt to establish a soft stimulation protocol. 2nd World Congress on Controversies in Obstetrics and Gynecology. Abstract book, p. 52.
8. Engel JB, Felberbaum RE, Ludwig M et al. 2002a Use of Cetrotide® in combination with clomiphene citrate and gonadotrophins: a suitable approach to friendly IVF? Human Reproduction 17, 2022-2026.
9. Engel JB, Felberbaum RE, Eilers W et al. 2002b Clomiphene-induced LH surges and cetrorelix. Reproductive BioMedicine Online 5, 109-111.
10. Felberbaum RE, Albano C, Ludwig M et al. 2000 Ovarian stimulation for assisted reproduction with HMG and midcycle administration of the GnRH-antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Human Reproduction 15, 1015-1020.
11. Hwang JL, Huang LW, Hsieh BC et al. 2003 Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles. Human Reproduction 18, 45-49.
12. Lehmann F, Baban N, Webber B 1988 Ovarian stimulation for in-vitro fertilisation: clomiphene and HMG. Human Reproduction 3, 11-21.
13. Ludwig M, Felberbaum RE, Devroey P et al. 2000 Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist cetrorelix in controlled ovarian stimulation for assisted reproduction. Archives of Gynecology and Obstetrics 264, 29-32.
14. Olivennes F, Fanchin R, Bouchard P et al. 1994 The single or dual administration of the gonadotropin-releasing hormone antagonist cetrorelix in an in vitro fertilisation-embryo transfer program. Fertility and Sterility 62, 468-476.
15. Olivennes F, Belaisch-Allart J, Emperaire JC et al. 2000 Prospective, randomized, conrolled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LHRH-agonist (triptorelin). Fertility and Sterility 73, 314-320.
16. Quigley MM 1984 The use of ovulation-inducing agents in in-vitro fertilisation. Clinical Obstetrics and Gynecology 27, 983-991.
17. Ronen J, Bosschieter J, Wiswedel K et al. 1988 Ovulation induction for in-vitro fertilisation using clomiphene citrate and low-dose human menopausal gonadotrophin. International Journal of Fertility 33, 120-122.
18. Shimizu I, Terakawa N, Aono T et al. 1986 Clomiphene citrate induces GnRH-receptors in ovariectomized rats: its possible role in induction of ovulation. Acta Endocrinology (Copenhagen) 111, 179-184.
19. Tummon IS, Daniel SAJ, Kaplan BR et al. 1992 Randomized, prospective comparison of luteal leuprolide acetate and gonadotrophins versus clomiphene citrate and gonadotrophins in 408 first cycles of in vitro fertilization. Fertility and Sterility 58, 563-568.
20. Zhioua F, Mahmoud K, Benaribia MH et al. 2000 Benefits of GnRH antagonists in ovarian stimulation. Conference abstract: 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. Fertility and Sterility 74, 177.